FDA new drug approvals hit 16-year high in 2012 | Reuters
U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after...
Patent cliff causes negative outlook for global pharma | Healthcare Finance News
The outlook for the global pharmaceutical industry remains negative as any potential revenue over the next 12-18 months is likely to be...
